Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus
Raphaële Germi(Centre National de la Recherche Scientifique), Patrice Morand, Julien Lupo(Université Joseph Fourier), Olivier Épaulard(Centre National de la Recherche Scientifique), Anne Thiébaut(Centre Hospitalier Universitaire de Grenoble), Paolo Malvezzi(Université Grenoble Alpes), Sophie Alain(Inserm), C. Saint Raymond(Université Grenoble Alpes), Jean‐Pierre Brion(Université Libre de Bruxelles), Clara Mariette(Université Grenoble Alpes)
Cited by 71
Related Papers
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
|The Lancet Infectious Diseases|2017|822
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299
Bacterial Populations Contaminating The Upper Gut in Patients With Small Intestinal Bacterial Overgrowth Syndrome
|The American Journal of Gastroenterology|1999|196
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2021|185
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
|Journal of Antimicrobial Chemotherapy|2010|163